News
The results of a blood test done immediately after heart surgery can be a meaningful indicator of postoperative stroke risk, a study by researchers at Wake Forest Baptist Medical Center has found.
April 02, 2015
News
Medtronic announced Japanese regulatory approval for the self-expanding transcatheter CoreValve system for patients with severe aortic stenosis (AS). Japanese regulatory authorities granted approval of the CoreValve system for transcatheter aortic valve implantation (TAVI) based on data from the CoreValve U.S. Pivotal Trials and the Medtronic CoreValve Japan Trial, which is the first study to evaluate a self-expandable transcatheter valve in the Japanese patient population.
April 02, 2015
News
SynCardia Systems Inc. has received U.S. Food and Drug Administration (FDA) approval to conduct an Investigational Device Exemption (IDE) clinical study on the effective use of its 50cc SynCardia temporary Total Artificial Heart.
April 02, 2015Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024Feature
Medtronic plc announced the initiation of the SPYRAL HTN Global Clinical Trial Program, a phased clinical program studying renal denervation in uncontrolled hypertension. This announcement follows investigational device exemption (IDE) approval by the U.S. Food and Drug Administration (FDA).
April 01, 2015News
UHC has released the findings of a new study that evaluated the use of medical devices based on cost and quality outcomes. The goal of the study was to uncover several trends related to high-priced physician preference items (PPIs). Utilization of PPIs — which can account for 30 to 40 percent of a hospital's supply expenses — at 10 academic medical centers, focusing on procedures utilizing orthopedic implants, coronary and peripheral stents and cardiac valves.
April 01, 2015
News
According to information technology (IT) company Logicalis US, managing a high volume of patient images in varying formats requires development of a comprehensive enterprise imaging strategy that addresses five core components while remaining vendor-neutral.
April 01, 2015Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News
Mobile Heartbeat announced it will be demonstrating its MH-CURE communication and workflow smartphone application at the 2015 Healthcare Information and Management Systems Society (HIMSS) annual conference, April 13-15, 2015, in Chicago.
March 31, 2015
News
The physician-patient relationship still plays a primary role in the overall patient experience despite increasing use of technology, according to a survey conducted by Nuance Communications Inc. The 3,000-person survey — conducted in the United States, United Kingdom and Germany — found that 97 percent of people agreed with this sentiment.
March 31, 2015
News
A new KLAS report on business intelligence (BI) found that healthcare organizations are looking for BI vendors with industry expertise and content to handle the growing complexities of data management. The report — entitled Health Analytics 2015: Moving toward the Continuum of Care — stresses that in-organization data is only a part of the picture and that data aggregation capabilities are more important than ever before.
March 31, 2015Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Technology
NavisHealth Solutions Inc. announced the general availability of its mobile patient engagement platform, Engage.
March 31, 2015
Technology
The U.S. Food and Drug Administration (FDA) expanded the approved use of the CoreValve self-expanding transcatheter aortic valve replacement (TAVR) system to treat certain patients who have previously had a tissue aortic valve replacement and are in need of a second one. This is the first transcatheter heart valve approved in the United States for valve-in-valve procedures in both high and extreme risk patients who have limited options or may otherwise go untreated.
March 31, 2015News
The Medicines Company announced that the European Commission has granted marketing authorization for two acute care products – Kengrexal (cangrelor) and Raplixa (sealant powder). These approvals follow the issuance of positive opinions in January by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA).
March 30, 2015Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Feature
A team of investigators at Children’s Hospital Los Angeles and the University of Southern California have developed the first fully implantable micropacemaker designed for use in a fetus with complete heart block. The team has done preclinical testing and optimization as reported in a recent issue of the journal Heart Rhythm.
March 30, 2015
Technology
AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has approved a new administration option for acute coronary syndrome (ACS) patients who are unable to swallow ticagrelor (Brilinta) 90 mg tablets whole. Unlike other P2Y12 inhibitors, ticagrelor has FDA approval to be crushed and administered in water by swallowing or via nasogastric tube.
March 30, 2015
News
Green Circle Health (GCH) announced the availability of its GCH Platform, an online patient-to-provider communications gateway. The platform enables the real-time exchange of patient vitals and health records among physicians, patients, family members and insurers. It leverages a patent-pending workflow to facilitate the collaborative sharing of data and enhance healthcare providers’ ability to proactively monitor, diagnose and treat medical conditions.
March 30, 2015© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now